Skip to main content
SpringerLink
Log in

Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen

  • Original Articles
  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

Daily injections of 100 μg17 β-estradiol, or 250 μg tamoxifen, for 10 days led to a regression of the 7,12-dimenthylbenz(a)anthracene (DMBA)-induced rat mammary tumor. Estrogen receptor (ER), progesterone receptor (PgR), and prolactin receptor (PRL-R) in the regressed tumor were significantly reduced in the estrogen-treated rats. ER and PRL-R were low but PgR increased significantly in the tumor of the tamoxifen-treated rats. A single administration of 100 μg estradiol induced a transient decrease of ER and PRL-R, and an increase of PgR, in the DMBA-tumor. Similar decreases in ER and PRL-R and the increase of PgR were observed 8 hours after the 5th injection of 100 μg estradiol—a time when the tumor had already regressed. These results suggest that high dose-estrogen has a direct inhibitory effect on the concentration of both ER and PRL-R in the DMBA-tumor, and that this effect might be accumulative with repeated administrations. It is unlikely that the inhibition of the estrogenic effect caused by loss of ER is the sole mechanism of the regression of the DMBA-tumor, since the increased synthesis of PgR as a marker of estrogen action was observed even after the ER-reduction and tumor-regression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boylan ES, Wittliff JL. Specific estrogen binding in rat mammary tumors induced by 7,12-dimethylbenzanthracene. Cancer Res 1975; 35: 506–511.

    PubMed  CAS  Google Scholar 

  2. Leung BS, Sasaki GH. On the mechanism of prolactin and estrogen action in 7,12-dimethylbenz(a)-anthracene-induced Mammary carcinoma in the rat.In vivo tumor responses and estrogen receptor. Endocrinology 1975; 97: 564–572.

    PubMed  CAS  Google Scholar 

  3. Turkington RW. Prolactin receptors in mammary carcinoma cells. Cancer Res 1974; 34: 758–763.

    PubMed  CAS  Google Scholar 

  4. Arafah BM, Manni A, Pearson OH. Effect of hypophysectomy and hormone receptor levels and growth of 7,12-dimenthylbenz(a)anthracene-induced mammary tumors in the rat. Endocrinology 1980; 107: 1364–1369.

    PubMed  CAS  Google Scholar 

  5. Hawkins RA, Roberts MM, Forrest APM. Oestrogen receptors and breast cancer: current status. Br J Surg 1980; 67: 153–169.

    PubMed  CAS  Google Scholar 

  6. Meites J, Cassell E, Clark J. Estrogen inhibition of mammary tumor growth in rats; counteraction by prolactin. Proc Soc Exp Biol Med 1971; 137: 1225–1227.

    PubMed  CAS  Google Scholar 

  7. Yanai R, Nagasawa H. Reduction by pituitary isograft of the inhibiting effect of large doses of estrogen on the incidence of mammary tumors induced by carcinogen in ovariectomized rats. Int J Cancer 1971; 8: 463–467.

    PubMed  Google Scholar 

  8. Kledzik GS, Bradley CJ, Marshall S, Compbell GA, Meites J. Effects of high doses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats. Cancer Res 1976; 36: 3265–3268.

    PubMed  CAS  Google Scholar 

  9. Tsai TLS, Rutledge S, Katzenellenbogen BS. Antiestrogen modulation of growth and properties of ovarian-autonomous and ovarian-dependent mammary tumors in rats. Cancer Res 1979; 39: 5043–5050.

    PubMed  CAS  Google Scholar 

  10. Manni A, Rainieri J, Arafah BM, Pearson OH. Effect of high-dose oestrogen administration on the growth and prolactin receptor content of N-nitrosomethylurea-induced mammary tumors in the rat. J Endocr 1982; 93: 11–16.

    PubMed  CAS  Google Scholar 

  11. Simon WE, Albrecht M, Trams G, Dietel M, Holzel F.In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin. J N C I 1984; 73: 313–321

    CAS  Google Scholar 

  12. Waseda N, Kato Y, Imura H, Kurata M. Prognostic values of estrogen and prolactin receptor analysis in human breast cancer. Gann 1985; 76: 517–523.

    PubMed  CAS  Google Scholar 

  13. Lemay LT, Kelly PA. Prolactin receptors in human breast tumors. J N C I 1982; 68: 381–383.

    Google Scholar 

  14. McGuire WL, Horwitz KB, Pearson OH, Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer 1977; 39: 2934–2947.

    Article  PubMed  CAS  Google Scholar 

  15. Nishimura R, Kimura M, Tokunaga T, Akagi M. Measurement of nuclear estrogen receptors by charcoal adsorption. Gann 1982; 73: 713–720.

    PubMed  CAS  Google Scholar 

  16. Nishimura R, Misumi A, Kimura M, Tokunaga T, Akagi M. Relationship between the content of estrogen and progesterone receptors and pathological characteristics in human breast cancer. Jpn J Surg 1982; 12: 191–197.

    Article  PubMed  CAS  Google Scholar 

  17. Scatchard G, Ann NY. The attraction of proteins for small molecules and ions. Acad Sci 1949; 51: 660–672.

    CAS  Google Scholar 

  18. Lowry OH, Rosebrough NJ, Farr AL, Randoll RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–275.

    PubMed  CAS  Google Scholar 

  19. Chen CL, Meites J. Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats. Endocrinology 1970; 86: 503–505.

    Article  PubMed  CAS  Google Scholar 

  20. Gala RR, Boss RS. Serum prolactin levels of rats under continuous estrogen stimulation and 2 br-α-ergocriptine (CB-154) injection. Proc Soc Exp Biol Med 1975; 149: 330–332.

    PubMed  CAS  Google Scholar 

  21. Posner BI, Kelly PA, Friesen HG. Prolactin receptors in rat liver: possible induction by prolactin. Science 1975; 188: 57–59.

    PubMed  CAS  Google Scholar 

  22. Manni A, Chambers MJ, Pearson ON. Prolactin induces its own receptor in rat liver. Endocrinology 1978; 103: 2168–2171.

    Article  PubMed  CAS  Google Scholar 

  23. Kato Y, Waseda N, Imura H, Kurata M. Cytosol & nuclear estrogen receptors and prolactin receptor in human breast cancer. Clinical Endocrinology 1979; 27: 851–857. (in Japanese)

    PubMed  CAS  Google Scholar 

  24. Namer M, Lalanne C, Baulieu EE. Increase of progesteron receptors by tamoxifen as a hormonal challenge test in breast cancer. Cancer Res 1980; 40: 1750–1752.

    PubMed  CAS  Google Scholar 

  25. Manni A, Baker R, Arafah BM, Pearson OH. Uterine oestrogen and progesterone receptors in the ovariectomized rat. J Endocr 1981; 91: 281–287.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Surgery, Kumamoto University Medical School, 1-1-1 Honjo, 860, Kumamoto, Japan

    Nobuyuki Shigaki, Masaharu Kimura, Sadamu Takano, Noboru Fujino & Masanobu Akagi

Authors
  1. Nobuyuki Shigaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masaharu Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sadamu Takano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Noboru Fujino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masanobu Akagi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shigaki, N., Kimura, M., Takano, S. et al. Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen. The Japanese Journal of Surgery 17, 395–401 (1987). https://doi.org/10.1007/BF02470640

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02470640

Key Words

Search

Navigation